Stockreport

Phathom's Voquezna: A Breakthrough Drug Facing Marketing Challenges [Seeking Alpha]

Phathom Pharmaceuticals, Inc.  (PHAT) 
Last phathom pharmaceuticals, inc. earnings: 3/19 08:31 am Check Earnings Report
PDF Follow Play 9min Summary Phathom Pharmaceuticals developed Voquezna, a first-in-class PCAB, licensed from Takeda, for acid-related disorders. Voquezna's FDA a [Read more]